Genuine Parts logo

Genuine PartsNYSE: GPC

Profile

Industry:

Auto Parts

Country:

United States

IPO:

17 March 1980

Next earnings report:

14 February 2025

Last dividends:

06 September 2024

Next dividends:

N/A
$17.34 B
-34%vs. 3y high
90%vs. sector
-35%vs. 3y high
42%vs. sector
-48%vs. 3y high
78%vs. sector
-40%vs. 3y high
48%vs. sector

Price

after hours | Tue, 19 Nov 2024 00:53:27 GMT
$124.68+$1.87(+1.52%)
$5.97 B$5.71 B
$5.97 B$226.58 M

Analysts recommendations

Institutional Ownership

GPC Latest News

Top Dividend Aristocrats To Buy Now After The Trump Sweep
seekingalpha.com09 November 2024 Sentiment: POSITIVE

A possible 15% corporate tax rate might lead to a major market surge, reminiscent of the excitement in 2017, increasing S&P 500 earnings by 4%. It's wise to concentrate on undervalued, high-quality dividend aristocrats in the consumer discretionary, materials, and industrial sectors, as they would gain the most from these tax reductions. These five aristocrats provide a 3.2% yield, a 10% annual growth in dividends, and a potential 33% increase in value over the next year, rising to 38% with the tax cuts.

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
prnewswire.com08 November 2024 Sentiment: POSITIVE

Recent research highlights the promise of in vivo CAR-M technology as a potential off-the-shelf treatment for hepatocellular carcinoma (HCC). Carisma Therapeutics Inc. has shared encouraging pre-clinical results for its anti-GPC3 CAR-M therapy, developed in partnership with Moderna, Inc. The findings show that this therapy can effectively generate CAR-M cells in the body, reprogramming natural immune cells to target and eliminate cancer cells that express Glypican-3 (GPC3).

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
prnewswire.com05 November 2024 Sentiment: POSITIVE

Pre-clinical research shows strong anti-tumor effects and a new ready-to-use method for treating GPC3+ solid tumors. Carisma Therapeutics Inc. will present new pre-clinical findings on its CAR-M therapy for hepatocellular carcinoma, developed with Moderna, at the Society for Immunotherapy of Cancer Annual Meeting in Houston on November 8, 2024.

Genuine Parts Stock: Not Cheap Enough To Buy, Yet
seekingalpha.com29 October 2024 Sentiment: NEGATIVE

Evaluating the risks and rewards is important when investing in stocks. The recent 20% decline in Genuine Parts Company's value calls for a reassessment of its investment potential. Since GPC is a slow-growing company, it should only be purchased at a significant discount for possible short-term gains, rather than as a long-term investment.

Why Genuine Parts Stock Investors Saw Red This Week
fool.com24 October 2024 Sentiment: NEGATIVE

The company's shares dropped after it reduced its earnings forecasts for 2024.

Genuine Parts Company: A Buy Opportunity Following The Recent Drop
seekingalpha.com23 October 2024 Sentiment: POSITIVE

Genuine Parts Company saw a notable 20% decrease in its stock price, currently valued at less than 12.2 times its normalized price-to-earnings ratio, with a yield exceeding 3.53%. Even with this decline, the company is a stable business that has been around for almost 100 years, holds a BBB rating, and has a market cap of over $15 billion, indicating it is not at risk of bankruptcy. The drop was caused by the results from the third quarter of 2024, but the company's strong fundamentals in automotive and industrial replacement parts suggest there may be potential for recovery.

Genuine Parts Company: We Double Down
seekingalpha.com23 October 2024 Sentiment: POSITIVE

Genuine Parts had disappointing results in the third quarter, which caused them to lower their forecasts significantly. However, sales are starting to stabilize, and their gross margin has improved. Due to potential mergers and acquisitions, a lower valuation, and the increasing age of car fleets, GPC is considered a good investment.

Genuine Parts (GPC) Reports Q3 Earnings: What Key Metrics Have to Say
zacks.com22 October 2024 Sentiment: POSITIVE

While the revenue and earnings per share (EPS) for Genuine Parts (GPC) provide insight into its performance for the quarter ending September 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.

Why Genuine Parts Stock Tumbled Today
fool.com22 October 2024 Sentiment: NEGATIVE

The stock prices of the auto parts company dropped after a disappointing earnings report was released.

Genuine Parts Company (GPC) Q3 2024 Earnings Call Transcript
seekingalpha.com22 October 2024 Sentiment: POSITIVE

Genuine Parts Company (NYSE:GPC) will hold its Q3 2024 Earnings Conference Call on October 22, 2024, at 8:30 AM ET. The call will feature company representatives including Tim Walsh, Will Stengel, and Bert Nappier, along with participants from various financial institutions. The operator will welcome everyone to the call.

What type of business is Genuine Parts?

Genuine Parts Company is an American distribution company headquartered in Atlanta, Georgia, specializing in the sale of automotive parts, components, and more. The company was founded in 1925. Currently, the company's trading network includes 3,600 locations across North America, Europe, Australia, and New Zealand. The company's activities are divided into several business segments: - Automotive Parts Group - distributes automotive parts and accessories. - Industrial Parts Group - distributes industrial parts and related consumables. - Business Products Group - wholesales a wide range of office and other products.

What sector is Genuine Parts in?

Genuine Parts is in the Consumer Cyclical sector

What industry is Genuine Parts in?

Genuine Parts is in the Auto Parts industry

What country is Genuine Parts from?

Genuine Parts is headquartered in United States

When did Genuine Parts go public?

Genuine Parts initial public offering (IPO) was on 17 March 1980

What is Genuine Parts website?

https://www.genpt.com

Is Genuine Parts in the S&P 500?

Yes, Genuine Parts is included in the S&P 500 index

Is Genuine Parts in the NASDAQ 100?

No, Genuine Parts is not included in the NASDAQ 100 index

Is Genuine Parts in the Dow Jones?

No, Genuine Parts is not included in the Dow Jones index

When was Genuine Parts the previous earnings report?

No data

When does Genuine Parts earnings report?

The next expected earnings date for Genuine Parts is 14 February 2025